Merck & Co., Inc. Goodwill, Other Changes (Deprecated 2016-01-31)
Merck & Co., Inc. (MRK) reported Goodwill, Other Changes (Deprecated 2016-01-31) of -$83.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-26.
Discontinued › Notes › Intangible Assets
us-gaap:GoodwillOtherChanges · last filed 2016-02-26
- Merck & Co., Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2015 was -$83.00M, a 236.07% decline from fiscal 2014.
- Merck & Co., Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2014 was $61.00M, a 22.78% decline from fiscal 2013.
- Merck & Co., Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2013 was $79.00M, a 276.19% increase from fiscal 2012.
- Merck & Co., Inc. goodwill, other changes (deprecated 2016-01-31) for fiscal 2012 was $21.00M, a 94.28% decline from fiscal 2011.
| Period end | Goodwill, Other Changes (Deprecated 2016-01-31) 12 month |
|---|---|
| 2015-12-31 | -$83.00M 10-K · filed 2016-02-26 |
| 2014-12-31 | $61.00M 10-K · filed 2016-02-26 |
| 2013-12-31 | $79.00M 10-K · filed 2015-02-27 |
| 2012-12-31 | $21.00M 10-K · filed 2014-02-27 |
| 2011-12-31 | $367.00M 10-K · filed 2013-02-28 |
| 2010-12-31 | -$174.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |